Medicinova (MNOV) Other Non-Current Assets (2010 - 2025)
Medicinova's (MNOV) quarterly Other Non-Current Assets came in at $4.8 million in Q4 2025, little changed year-on-year from $4.8 million in Q4 2024, and little changed on a QoQ basis from $4.8 million in Q3 2025.
Medicinova (MNOV) Other Non-Current Assets (2010 - 2025) Analysis & Trends
Medicinova (MNOV) has 16 years of Other Non-Current Assets data on file, last reported at $4.8 million in Q4 2025.
- On a quarterly basis, Other Non-Current Assets changed 0.0% year-over-year to $4.8 million in Q4 2025; TTM through Dec 2025 was $4.8 million, a 0.0% change from a year earlier, with the FY2025 full-year figure at $4.8 million, changed 0.0% from the prior year.
- Other Non-Current Assets for Q4 2025 stood at $4.8 million, roughly flat from $4.8 million in the prior quarter.
- Over the last five years, Other Non-Current Assets for MNOV reached as high as $4.8 million in Q1 2021 and fell as low as $18996.0 in Q2 2024.
- Historically, Other Non-Current Assets has averaged $2.9 million across 5 years, with a median of $4.8 million in 2021.
- Across the five-year window, Other Non-Current Assets plunged 99.6% in 2024 and surged 25168.48% in 2025, its largest moves.
- Year by year, Other Non-Current Assets stood at $4.8 million in 2021, then tumbled by 98.07% to $92792.0 in 2022, then slipped by 20.09% to $74151.0 in 2023, then soared by 6373.28% to $4.8 million in 2024, then changed by 0.0% to $4.8 million in 2025.
- Per Business Quant data, the three most recent Other Non-Current Assets figures were $4.8 million in Q4 2025, $4.8 million in Q3 2025, and $4.8 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 1.02 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 104.24 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.26 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 2.13 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 289.41 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 124.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 14.48 Mn |
| 10 | Medicinova | 64.48 Mn | 64.48 Mn | 4,754.00 | 4.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 4.80 Mn |
| Sep 30, 2025 | 4.80 Mn |
| Jun 30, 2025 | 4.80 Mn |
| Mar 31, 2025 | 4.80 Mn |
| Dec 31, 2024 | 4.80 Mn |
| Sep 30, 2024 | 18,996.00 |
| Jun 30, 2024 | 18,996.00 |
| Mar 31, 2024 | 4.80 Mn |
| Dec 31, 2023 | 74,151.00 |
| Sep 30, 2023 | 71,067.00 |
| Jun 30, 2023 | 4.80 Mn |
| Mar 31, 2023 | 4.80 Mn |
| Dec 31, 2022 | 92,792.00 |
| Sep 30, 2022 | 4.80 Mn |
| Jun 30, 2022 | 105,059.00 |
| Mar 31, 2022 | 4.80 Mn |
| Dec 31, 2021 | 4.80 Mn |
| Sep 30, 2021 | 117,538.00 |
| Jun 30, 2021 | 305,328.00 |
| Mar 31, 2021 | 4.80 Mn |